Alerts will be sent to your verified email
Verify Email
TRIMURTHI
|
Novelix Pharma
|
Maharashtra Corpn.
|
Dhyaani Tradeventtur
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-17.5 % | -0.65 % | 7.57 % |
|
5yr average Equity Multiplier
|
1.26 | 1.02 | 47.77 |
|
5yr Average Asset Turnover Ratio
|
0.84 | 0.02 | 1.06 |
|
5yr Avg Net Profit Margin
|
-14.11 % | 17.08 % | 1.27 % |
|
Price to Book
|
3.61 | 0.42 | 0.0 |
|
P/E
|
130.43 | 29.5 | 37.55 |
|
5yr Avg Cash Conversion Cycle
|
29.1 Days | 2867.17 Days | -9.57 Days |
|
Inventory Days
|
34.04 Days | 526.89 Days | 4.04 Days |
|
Days Receivable
|
55.38 Days | 2142.83 Days | 313.08 Days |
|
Days Payable
|
55.7 Days | 52.42 Days | 354.56 Days |
|
5yr Average Interest Coverage Ratio
|
-17.77 | 1636.08 | 465.7 |
|
5yr Avg ROCE
|
-15.4 % | -0.64 % | -10.69 % |
|
5yr Avg Operating Profit Margin
|
-16.49 % | 19.4 % | -0.75 % |
|
5 yr average Debt to Equity
|
0.05 | 0.01 | 2.38 |
|
5yr CAGR Net Profit
|
35.78 % | n/a | n/a |
|
5yr Average Return on Assets
|
-13.36 % | -0.64 % | 2.17 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
66.56 % | 16.62 % | 5.66 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.36 % | 3.35 % | -60.66 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Novelix Pharma
|
Maharashtra Corpn.
|
Dhyaani Tradeventtur
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|